Research output

Balancing benefits and risks in the era of biologics

Research output: Contribution to journalReview articleAcademicpeer-review

Associated researcher

  • Adami, G.
  • Saag, K. G.
  • Chapurlat, R. D.
  • Guanabens, N.
  • Haugeberg, G.
  • Lems, W. F.
  • Matijevic, R.
  • Peel, N.
  • Poddubnyy, D.
  • Geusens, P.M.M.

Associated organisations

    Research areas

  • benefit-risk ratio, biologics, denosumab, romosozumab, POSTMENOPAUSAL WOMEN, RHEUMATOID-ARTHRITIS, CERTOLIZUMAB PEGOL, ROMOSOZUMAB, PREVENTION, INFLIXIMAB, FRACTURES, DENOSUMAB, DISEASES, SAFETY
View graph of relations

Details

Original languageEnglish
Article numberUNSP 1759720X19883973
Number of pages6
JournalTherapeutic Advances in Musculoskeletal Disease
Volume11
DOIs
Publication statusPublished - Oct 2019